The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Endothelial-to-mesenchymal transition drives atherosclerosis progression
Open accessAbstract
The molecular mechanisms responsible for the development and progression of atherosclerotic lesions have not been fully established. Here, we investigated the role played by endothelial-to-mesenchymal transition (EndMT) and its key regulator FGF receptor 1 (FGFR1) in atherosclerosis. In cultured human endothelial cells, both inflammatory cytokines and oscillatory shear stress reduced endothelial FGFR1 expression and activated TGF-β signaling. We further explored the link between disrupted FGF endothelial signaling and progression of atherosclerosis by introducing endothelial-specific deletion of FGF receptor substrate 2 α (Frs2a) in atherosclerotic (Apoe(-/-)) mice. When placed on a high-fat diet, these double-knockout mice developed atherosclerosis at a much earlier time point compared with that their Apoe(-/-) counterparts, eventually demonstrating an 84% increase in total plaque burden. Moreover, these animals exhibited extensive development of EndMT, deposition of fibronectin, and increased neointima formation. Additionally, we conducted a molecular and morphometric examination of left main coronary arteries from 43 patients with various levels of coronary disease to assess the clinical relevance of these findings. The extent of coronary atherosclerosis in this patient set strongly correlated with loss of endothelial FGFR1 expression, activation of endothelial TGF-β signaling, and the extent of EndMT. These data demonstrate a link between loss of protective endothelial FGFR signaling, development of EndMT, and progression of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Mechanotransduction in vascular physiology and atherogenesis
Hahn, C., & Schwartz, M. A. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2596 · Cited by 1,211
Self-citationRecent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016 · cited 1×
“The two key factors regulating endothelial FGFR1 expression, disturbed shear stress and vessel wall inflammation, are also well-known atherosclerosis risk factors (1, 5).”
BackgroundIFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Conversion of vascular endothelial cells into multipotent stem-like cells
Medici, D., Shore, E. M., Lounev, V. Y., Kaplan, F. S., Kalluri, R., & Olsen, B. R. (2010) · Nature Medicine · doi:10.1038/nm.2252 · Cited by 678
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Libby, P., Lichtman, A. H., & Hansson, G. K. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.009 · Cited by 671
Distribution of macrophage polarization markers in human atherosclerosis
Stöger, J. L., Gijbels, M. J. J., van der Velden, S., Manca, M., van der Loos, C. M., Biessen, E. A. L., Daemen, M. J. A. P., Lutgens, E., & de Winther, M. P. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.013 · Cited by 621
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.001 · Cited by 580
EndMT contributes to the onset and progression of cerebral cavernous malformations
Maddaluno, L., Rudini, N., Cuttano, R., Bravi, L., Giampietro, C., Corada, M., Ferrarini, L., Orsenigo, F., Papa, E., Boulday, G., et al. (2013) · Nature · doi:10.1038/nature12207 · Cited by 486 · cited 1×
“Recent studies have documented a high incidence of endothelial-to-mesenchymal transition (EndMT) in a number of pathological conditions associated with inflammation, such as myocardial infarction (6), cerebral cavernous malformations (7), portal hypertension (8), pulmonary hypertension (9), and vascular graft failure…”
BackgroundInducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice
Pitulescu, M. E., Schmidt, I., Benedito, R., & Adams, R. H. (2010) · Nature Protocols · doi:10.1038/nprot.2010.113 · Cited by 418
TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft Remodeling
Cooley, B. C., Nevado, J., Mellad, J., Yang, D., St. Hilaire, C., Negro, A., Fang, F., Chen, G., San, H., Walts, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006927 · Cited by 392
Interferon-γ elicits arteriosclerosis in the absence of leukocytes
Tellides, G., Tereb, D. A., Kirkiles-Smith, N. C., Kim, R. W., Wilson, J. H., Schechner, J. S., Lorber, M. I., & Pober, J. S. (2000) · Nature · doi:10.1038/35003221 · Cited by 391
Self-citationEverett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368 · cited 1×
“Various attempts to suppress specific aspects of inflammation, including an IL-1β–neutralizing antibody (CANTOS) (31), have been equivocal at best.”
BackgroundRegulation of endothelial cell plasticity by TGF-β
van Meeteren, L. A., & ten Dijke, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1222-6 · Cited by 333
Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma
Scanlon, C. S., Van Tubergen, E. A., Inglehart, R. C., & D’Silva, N. J. (2013) · Journal of Dental Research · doi:10.1177/0022034512467352 · Cited by 331
Lutgens, E., Gijbels, M., Smook, M., Heeringa, P., Gotwals, P., Koteliansky, V. E., & Daemen, M. J. A. P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000019729.39500.2f · Cited by 313
Jung, H.-Y., Fattet, L., & Yang, J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3173 · Cited by 309
Chen, P.-Y., Qin, L., Barnes, C., Charisse, K., Yi, T., Zhang, X., Ali, R., Medina, P. P., Yu, J., Slack, F. J., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.021 · Cited by 304
Self-citationAdaptive immunity in atherosclerosis: mechanisms and future therapeutic targets
Lahoute, C., Herbin, O., Mallat, Z., & Tedgui, A. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.62 · Cited by 229
Toma, I., & McCaffrey, T. A. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1189-3 · Cited by 193
Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis
Tan, M. H., Sun, Z., Opitz, S. L., Schmidt, T. E., Peters, J. H., & George, E. L. (2004) · Blood · doi:10.1182/blood-2003-09-3363 · Cited by 178
IFN- γ Deficiency Exerts Gender-Specific Effects on Atherogenesis in Apolipoprotein E -/- Mice
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260100141 · Cited by 176
Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling
Baeyens, N., Mulligan-Kehoe, M. J., Corti, F., Simon, D. D., Ross, T. D., Rhodes, J. M., Wang, T. Z., Mejean, C. O., Simons, M., Humphrey, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413725111 · Cited by 171
Self-citationFeaver, R. E., Gelfand, B. D., Wang, C., Schwartz, M. A., & Blackman, B. R. (2010) · Circulation Research · doi:10.1161/circresaha.109.216283 · Cited by 136
Self-citationPlasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation
Rohwedder, I., Montañez, E., Beckmann, K., Bengtsson, E., Dunér, P., Nilsson, J. Å., Soehnlein, O., & Fässler, R. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200237 · Cited by 128
Fibroblast growth factor receptor 1 is a key inhibitor of TGFβ signaling in the endothelium
Chen, P., Qin, L., Tellides, G., & Simons, M. (2014) · Science Signaling · doi:10.1126/scisignal.2005504 · Cited by 113
Self-citationMallat, Z., & Tedgui, A. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00008 · Cited by 99
Kitao, A., Sato, Y., Sawada‐Kitamura, S., Harada, K., Sasaki, M., Morikawa, H., Shiomi, S., Honda, M., Matsui, O., & Nakanuma, Y. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081061 · Cited by 92
Flow-dependent cellular mechanotransduction in atherosclerosis
Conway, D. E., & Schwartz, M. A. (2013) · Journal of Cell Science · doi:10.1242/jcs.138313 · Cited by 91
Self-citationTGF-β Signaling in Endothelial-to-Mesenchymal Transition: The Role of Shear Stress and Primary Cilia
ten Dijke, P., Egorova, A., Goumans, M., Poelmann, R., & Hierck, B. (2012) · Science Signaling · doi:10.1126/scisignal.2002722 · Cited by 88
Gelfand, B. D., Meller, J., Pryor, A. W., Kahn, M., Schoppee, P. D., Wamhoff, B. R., & Blackman, B. R. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227827 · Cited by 65
Generation of anFgf9 conditional null allele
Lin, Y., Liu, G., & Wang, F. (2006) · genesis · doi:10.1002/gene.20194 · Cited by 62
Huang, Q., Qin, L., Dai, S., Zhang, H., Pasula, S., Zhou, H. J., Chen, H., & Wang, M. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301220 · Cited by 48
Self-citationThe role of the inflammasome in cardiovascular diseases
Li, X., Deroide, N., & Mallat, Z. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1144-3 · Cited by 44
Generation of an Frs2α conditional null allele
Lin, Y., Zhang, J., Zhang, Y., & Wang, F. (2007) · genesis · doi:10.1002/dvg.20327 · Cited by 41
Cited by
Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000096 · Cited by 1,142
Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases
Piera-Velazquez, S., & Jimenez, S. A. (2019) · Physiological Reviews · doi:10.1152/physrev.00021.2018 · Cited by 662
Endothelial to Mesenchymal Transition in Cardiovascular Disease
Kovacic, J. C., Dimmeler, S., Harvey, R. P., Finkel, T., Aikawa, E., Krenning, G., & Baker, A. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.089 · Cited by 631
Evrard, S. M., Lecce, L., Michelis, K. C., Nomura-Kitabayashi, A., Pandey, G., Purushothaman, K.-R., d’Escamard, V., Li, J. R., Hadri, L., Fujitani, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11853 · Cited by 620
Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
Depuydt, M. A. C., Prange, K. H. M., Slenders, L., Örd, T., Elbersen, D., Boltjes, A., de Jager, S. C. A., Asselbergs, F. W., de Borst, G. J., Aavik, E., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316770 · Cited by 594
Metadata
- Authors
- Chen, P.-Y., Qin, L., Baeyens, N., Li, G., Afolabi, T., Budatha, M., Tellides, G., Schwartz, M. A., & Simons, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2015-10-26
- Volume
- 125
- Issue
- 12
- Pages
- 4514-4528
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2115542035
- Cited by
- 588
- References
- 39
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.